REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/04/2025
Back to search
Official data from USPTO
LEUKOTAC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LEUKOTAC
ST13
US500000087849391Class
5, 42, 44
Filing
87849391
Registration
6115761
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
08/05/2025
Trademark type
Word
Nice classes
5, 42, 44
Filing date
03/26/2018
Registration date
08/04/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/04/2020
Last transaction
08/05/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
03
Owner location
MILAN, IT
Examiner
GARTNER, JOHN
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
MEDIOLANUM FARMACEUTICI S.P.A.
E. B. (pessoa física)
Representatives
Michelle P. Ciotola CANTOR COLBURN LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for immuno-oncology and autoimmune disease; pharmaceutical preparationsimmunotherapy monoclonal antibodies for immuno-oncology and for the treatment of autoimmune diseases; veterinary preparations for immuno-oncology and autoimmune disease; veterinary preparationsimmunotherapy monoclonal antibodies for immuno-oncology and for the treatment of autoimmune diseases; biotechnological preparations for medical and veterinary useimmunotherapy monoclonal antibodies for immuno-oncology and for the treatment of autoimmune diseases
Class 42
Research and consultancy in the field of biotechnology; research and development in the field of biotechnology; scientific and technical consultationengineering evaluations and appraisals in the fields of science and technology; scientific and technology research in the field of immuno-oncology and autoimmune disease; laboratory research and analysis services in the field of immuno-oncology and autoimmune disease; scientific chemistrybiology and biotechnology laboratories; scientific laboratory services; laboratory testingresearch and development of new products for others; conducting clinical trials for others in the field of medicinesmolecules and medical devices; medical laboratory analysis services relating to the treatment of persons; medical laboratory servicesincluding sample analysis; medical laboratory analysis services
Class 44
Medical services; pharmaceutical advice
Publications
History of USPTO decisions and trademark events.
37 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/24/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
08/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/19/2020
PUBO
PUBLISHED FOR OPPOSITION
05/19/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/29/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/14/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/10/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/10/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/10/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/03/2020
GNFR
FINAL REFUSAL E-MAILED
04/03/2020
CNFR
FINAL REFUSAL WRITTEN
04/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/26/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/26/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/24/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/24/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/24/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/24/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/24/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/24/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
08/28/2019
GNSI
INQUIRY TO SUSPENSION E-MAILED
08/28/2019
CNSI
SUSPENSION INQUIRY WRITTEN
08/28/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
02/28/2019
GNSL
LETTER OF SUSPENSION E-MAILED
02/28/2019
CNSL
SUSPENSION LETTER WRITTEN
02/28/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/17/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/17/2019
ALIE
ASSIGNED TO LIE
01/17/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/14/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/12/2018
GNRT
NON-FINAL ACTION E-MAILED
07/12/2018
CNRT
NON-FINAL ACTION WRITTEN
07/12/2018
DOCK
ASSIGNED TO EXAMINER
07/11/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/02/2018
NWAP
NEW APPLICATION ENTERED
03/29/2018
Continuous trademark protection
Get notified about every new filing that threatens LEUKOTAC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.